- Both support neurological health, but hydroxocobalamin also enhances red blood cell production more effectively
Cardiovascular health: Recent Australia studies suggest the peptide may influence nitric oxide pathways, enhancing its therapeutic potential
The diagnostic process typically involves: Clinical history taking, focusing on symptoms (fatigue, neurological changes, dietary habits) Physical examination for signs of anaemia or neurological impairment Blood tests including full blood count, serum B12, and often folate levels Additional investigations such as intrinsic factor antibodies or parietal cell antibodies if pernicious anaemia is suspected For borderline results, additional tests like holotranscobalamin (active B12) may be considered NICE guidance recommends that treatment should commence based on clinical presentation if neurological symptoms are present, without waiting for laboratory confirmation, as delays can result in irreversible nerve damage
Legal status (US): IGF-1 LR3 itself has never been approved by the FDA for any human indication
Frontiers in Pharmacology, 12, 628920
Form Lyophilized vial (long-term) Temperature -4 F (-20 C) or colder Note Best for long storage